One must learn from mistakes... I hope they do not make the same mistake again. The value statement behind their business is solid but, being doctors, scientists etc. that they are, they rely too much on shareholders having empathy.... which they do not
I agree with previous posts that BOT will definitely come back as soon as someone with business delivery acumen explains to them the correct value added reporting processes to their shareholders.
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-82
-
- There are more pages in this discussion • 569 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.005(1.43%) |
Mkt cap ! $627.0M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 36.0¢ | 34.5¢ | $1.255M | 3.601M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 206282 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 316320 | 5 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |